close
Investment
3 mins to read

Kiwi startup Scentian Bio gets US$1.7m Gates Foundation grant

The company is developing a biological electronic nose that can detect human diseases.

Scentian Bio founder and chief technology officer Dr Andrew Králíček.

Kiwi startup Scentian Bio – which is developing a biological electronic nose, that among other things, could detect human diseases such as tuberculosis and malaria –has been awarded a US$1.7m grant by the Bill & Melinda Gates Foundation.

The Plant & Food Research spin-out is harnessing the power

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace
NZ Aviation News

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Aviation News - Monthly

NZ$14.95 / monthly

Already have an account? Login
Fiona Rotherham Thu, 03 Nov 2022
Contact the Writer: fiona@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Kiwi startup Scentian Bio gets US$1.7m Gates Foundation grant
Investment,
96450